JP Morgan 2021 Virtual Healthcare Conference: A Course Correction…
David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual format, noting potential changes in…
Tagged with Global
Embryonic Gene Editing: How Far is Too Far to Find a Treatment…
Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing. With CRISPR technology again in the…
Ipsen CEO David Loew on M&A, Rare Disease Expansion, Niche…
In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the…
Top 4 Global Vaccine Companies
Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines. Moreover, vaccines are an important…
Securing Trust in the COVID-19 Supply Chain: From Development…
Scientists have come together in an unparalleled worldwide collaboration and sharing of data to advance a COVID-19 vaccine.[1] As rollouts become…
Larry St Onge – President, Life Sciences and Healthcare,…
DHL’s Larry St Onge outlines how the logistics giant adapted to the COVID-19 pandemic in 2020, the unprecedented cross-industry collaboration that…
HIV: Janssen’s Johan Van Hoof on Search for The Vaccine ‘Holy…
With several COVID-19 vaccines gaining regulatory approval across the world in record time, a spotlight has been shone on the vaccines field more…
5 Trends for Life Science Companies to Watch in 2021
After a transformative 2020, Shawview Consulting’s Brendan Shaw looks into his crystal ball and makes five predictions (plus one) on the key trends…
2020’s Top 7 Biotech IPOs in Profile
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you profiles of the seven biggest biotech…
PharmaBoardroom’s Top Women Leaders 2020
While great strides in gender diversity has been made within healthcare boardrooms and leadership teams globally, as well as more generally across the…
Cell & Gene Therapy: CRISPR-Cas9 Nobel Prize Pioneers in…
On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development…
Thomas D. Madden – CEO, Acuitas Therapeutics
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…
